25
colon cancer
Skip itSoft demand (-69.7% this quarter) — this niche doesn't clear our bar today.
Review moat
Incredible57.33avg incumbent reviews — the moat a new listing must climb
Returns
Great1.8%return rate — above 5% kills the launch gate
Avg price
Good$14.24avg listing price — sweet spot $15–$100
Price range
Okay$9.31–$19.44cheapest to priciest tracked listing — scored on the share inside $15–$100
Conversion
Bad1.9%search→purchase rate — share of searches ending in a sale
Quality gap
Bad4.6★avg incumbent rating — lower means beatable quality
Market size
Bad$45K$45K/yr · 162K searches
Growth
Bad-69.7%90-day search growth — must beat 0% to launch
Competition
Bad100%top-5 click share — a locked-up shelf
Brand share
Bad100%top-5 brand share — brand-locked demand
Signals Low Review Barrier